Phase 2 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand what the study involves and are willing to sign a consent form agreeing to take part.
- You have already completed a specific visit (either the Week 18 check-up or the final visit) in one of two related previous studies (called CM512-101102 or CM512-100001).
Who may not be able to join:
- Not enough time has passed since your last treatment to allow it to clear your system before joining this trial (confirm with trial site).
- The study doctor decides, for any other reason, that it would not be appropriate for you to take part.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianzhong Zhang, Peking University People's Hospital
Phone: +86-028-88610620
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.